Bispectral Index Monitoring of Sedation During Endoscopic Retrograde Cholangiopancreaticography

NCT00952458 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2012-08-24

No results posted yet for this study

Summary

This randomized study investigates the benefits of an additional Bispectral Index monitoring of depth of sedation during endoscopic retrograde cholangiopancreaticography. A bispectral index (BIS) monitor is a neurophysiological monitoring device which continually analyses a patient's electroencephalograms during general anaesthesia to assess the level of consciousness during anaesthesia.

Conditions

  • Gastrointestinal Endoscopy
  • Sedation

Interventions

DEVICE

BIS monitoring

Neuromonitoring of depth of sedation with Bispectral Index

Sponsors & Collaborators

  • Medtronic - MITG

    collaborator INDUSTRY
  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Stefan von Delius, MD · Klinikum rechts der Isar der Technischen Universität München

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Germany

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00952458 on ClinicalTrials.gov